CRDF logo

Cardiff Oncology, Inc. (CRDF)

Profile

Full Name

Cardiff Oncology, Inc.

Ticker

NASDAQ: CRDF

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 27, 2004

Indexes

Not included

Website

https://www.cardiffoncology.com

Employees

32

Key Details

Price

$2.10(+0.96%)

Market cap

$139.70M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$683.00K(+39.96% YoY)

Annual EPS

-$0.95(-2.15% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.10
    CRDF price is $2.10

    30-Day Relative Volume

    0.35
    CRDF 30-day relative volume is 0.35

    Price Performance

    Price Most recent change

    +0.96%
    CRDF price was up +0.96% on Aug 29, 2025

    Price YTD change

    -51.61%
    CRDF price is down -51.61% since January 1st

    Price 1-year change

    -8.7%
    CRDF price is down -8.7% year-on-year

    Price 3-year change

    -14.98%
    CRDF price is down -14.98% over the past 3 years

    Price Range

    Price All-time high

    $2030.40
    CRDF price is currently -99.90% below its historical high of $2030.40

    Price 3-year low

    $0.94
    CRDF price is currently +123.40% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $139.70M
    CRDF market capitalization is $139.70 million

    Market cap 3-year change

    +30.52%
    CRDF market capitalization is up +30.52% over the past 3 years

    Market cap All-time high

    $872.87M
    CRDF market capitalization is currently -83.99% below its historical high of $872.87 million

    Market cap sector rank

    46.27%
    CRDF market capitalization is higher than 46.27% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +42.91%
    CRDF shares outstanding is up +42.91% year-on-year

    Shares Outstanding 3-Year Change

    +53.52%
    CRDF shares outstanding is up +53.52% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.25
    CRDF beta is 1.25

    200-day SMA

    $3.37
    CRDF price is currently -37.77% below its 200-day simple moving average

    50-day SMA

    $3.11
    CRDF price is currently -32.47% below its 50-day simple moving average

    RSI

    29.79
    CRDF 14-day relative strength index is 29.79

    Volume

    0.35
    CRDF 30-day relative volume is 0.35

    ATR

    $0.18
    CRDF average true range is $0.18

    10-day Historical Volatility

    40.96%
    CRDF 10-day historical volatility is 40.96%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $683.00K
    CRDF annual revenue is $683.00 thousand

    Revenue Analysts estimate

    $427.50K
    CRDF annual revenue is currently +59.77% higher than the consensus analysts' forecast

    Revenue 1-year change

    +39.96%
    CRDF annual revenue is up +39.96% year-on-year

    Revenue Sector rank

    36.3%
    CRDF annual revenue is higher than 36.3% of companies in Healthcare sector

    EPS

    EPS

    -$0.95
    CRDF annual earnings per share is -$0.95

    EPS Analysts estimate

    -$0.85
    CRDF annual earnings per share is currently +11.99% higher than the consensus analysts' forecast

    EPS 1-year change

    -2.15%
    CRDF annual earnings per share is down -2.15% year-on-year

    EPS Sector rank

    53.24%
    CRDF annual earnings per share is higher than 53.24% of companies in Healthcare sector

    Profit

    Gross profit

    $279.00K
    CRDF annual gross profit is $279.00 thousand

    Gross margin

    40.85%
    CRDF annual gross profit margin is 40.85%

    Operating profit

    -$48.65M
    CRDF annual operating income is -$48.65 million

    Operating margin

    -7123.13%
    CRDF annual operating profit margin is -7123.13%

    Net income

    -$45.43M
    CRDF annual net profit is -$45.43 million

    Net margin

    -6651.68%
    CRDF annual net profit margin is -6651.68%

    Expenses

    Total expenses

    $46.11M
    CRDF annual total expenses is $46.11 million

    Operating expenses

    $48.93M
    CRDF annual total operating expenses is $48.93 million

    Cost of goods sold

    $404.00K
    CRDF annual cost of goods sold is $404.00 thousand

    Selling, general & administrative expenses

    $0.00
    CRDF annual SGA is $0.00

    Depreciation and amortization

    $404.00K
    CRDF annual depreciation & amortization is $404.00 thousand

    Interest expense

    $0.00
    CRDF annual interest expense is $0.00

    Income tax

    $0.00
    CRDF annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$48.65M
    CRDF annual earnings before interest & taxes is -$48.65 million

    EBITDA

    -$48.25M
    CRDF annual EBITDA is -$48.25 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $97.19M
    CRDF annual total assets is $97.19 million

    Non current assets

    $2.14M
    CRDF annual long term assets is $2.14 million

    Current assets

    $95.05M
    CRDF annual total current assets is $95.05 million

    Cash and cash equivalents

    $91.75M
    CRDF annual cash & cash equivalents is $91.75 million

    Accounts receivable

    $773.00K
    CRDF annual accounts receivable is $773.00 thousand

    Inventory

    $0.00
    CRDF annual inventory is $0.00

    Liabilities

    Total liabilities

    $14.24M
    CRDF annual total liabilities is $14.24 million

    Long term liabilities

    $813.00K
    CRDF annual total long term liabilities is $813.00 thousand

    Current liabilities

    $13.43M
    CRDF annual total current liabilities is $13.43 million

    Accounts payable

    $4.82M
    CRDF annual accounts payable is $4.82 million

    Debt

    Total debt

    $1.52M
    CRDF annual total debt is $1.52 million

    Total debt 1-year change

    -29.13%
    CRDF annual total debt is down -29.13% year-on-year

    Long term debt

    $813.00K
    CRDF annual long term debt is $813.00 thousand

    Short term debt

    $710.00K
    CRDF annual short term debt is $710.00 thousand

    Equity & Capital

    Shareholders equity

    $82.95M
    CRDF annual stockholders equity is $82.95 million

    Book value

    $82.95M
    CRDF annual book value is $82.95 million

    Retained earnings

    -$384.18M
    CRDF annual retained earnings is -$384.18 million

    Working capital

    $81.63M
    CRDF annual working capital is $81.63 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$37.69M
    CRDF annual cash flow from operations is -$37.69 million

    Cash from operations 1-year change

    -22.04%
    CRDF annual cash flow from operations is down -22.04% year-on-year

    Cash from investing

    $13.73M
    CRDF annual cash flow from investing activities is $13.73 million

    Cash from investing 1-year change

    -62.07%
    CRDF annual cash flow from investing activities is down -62.07% year-on-year

    Cash from financing

    $53.78M
    CRDF annual cash flow from financing activities is $53.78 million

    Cash from financing 1-year change

    +100%
    CRDF annual cash flow from financing activities is up +100% year-on-year

    CAPEX

    CAPEX

    $80.00K
    CRDF annual capital expenditures is $80.00 thousand

    CAPEX 1-year change

    -86.25%
    CRDF annual capital expenditures is down -86.25% year-on-year

    Free Cash Flow

    Free cash flow

    -$37.77M
    CRDF annual free cash flow is -$37.77 million

    Free cash flow 1-year change

    -20.03%
    CRDF annual free cash flow is down -20.03% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    40.85%
    CRDF annual gross profit margin is 40.85%

    Operating margin

    -7123.13%
    CRDF annual operating profit margin is -7123.13%

    Net margin

    -6651.68%
    CRDF annual net profit margin is -6651.68%

    ROA & ROE

    ROA

    -50.81%
    CRDF annual return on assets is -50.81%

    ROE

    -59.51%
    CRDF annual return on equity is -59.51%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CRDF price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CRDF price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.38
    CRDF price to book ratio is 2.38

    PB ratio Sector rank

    58.94%
    CRDF price to book ratio is higher than 58.94% of companies in Healthcare sector

    PS Ratio

    PS ratio

    255.87
    CRDF price to sales ratio is 255.87

    PS ratio Sector rank

    93.87%
    CRDF price to sales ratio is higher than 93.87% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $69.93M
    CRDF enterprise value is $69.93 million

    Enterprise value Sector rank

    43.7%
    CRDF enterprise value is higher than 43.7% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.30
    CRDF EV/EBITDA is -1.30

    EV/EBITDA Sector rank

    43.24%
    CRDF EV/EBITDA is higher than 43.24% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.08
    CRDF annual current ratio is 7.08

    Quick ratio

    7.08
    CRDF annual quick ratio is 7.08

    Leverage

    Debt to equity

    0.02
    CRDF annual debt to equity ratio is 0.02

    Interest coverage ratio

    -
    CRDF annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    2
    CRDF piotroski f-score is 2

    Altman Z-Score

    -0.29
    CRDF altman z-score is -0.29

    Analyst ratings

    Recent major analysts updates

    Aug 6, 25 HC Wainwright & Co.
    Buy
    Jul 8, 25 Ladenburg Thalmann
    Buy
    Jun 24, 25 Jefferies
    Hold
    May 9, 25 HC Wainwright & Co.
    Buy
    Feb 28, 25 HC Wainwright & Co.
    Buy
    Dec 13, 24 Piper Sandler
    Overweight
    Nov 8, 24 HC Wainwright & Co.
    Buy
    Sep 6, 24 Craig-Hallum
    Buy
    May 6, 24 HC Wainwright & Co.
    Buy
    Mar 6, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with CRDF included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Cardiff Oncology, Inc.?
    • Does Cardiff Oncology, Inc. pay dividends?
    • What sector is Cardiff Oncology, Inc. in?
    • What industry is Cardiff Oncology, Inc. in?
    • What country is Cardiff Oncology, Inc. based in?
    • When did Cardiff Oncology, Inc. go public?
    • Is Cardiff Oncology, Inc. in the S&P 500?
    • Is Cardiff Oncology, Inc. in the NASDAQ 100?
    • Is Cardiff Oncology, Inc. in the Dow Jones?
    • When was Cardiff Oncology, Inc.'s last earnings report?
    • When does Cardiff Oncology, Inc. report earnings?

    What is the ticker symbol for Cardiff Oncology, Inc.?

    The ticker symbol for Cardiff Oncology, Inc. is NASDAQ:CRDF

    Does Cardiff Oncology, Inc. pay dividends?

    No, Cardiff Oncology, Inc. does not pay dividends

    What sector is Cardiff Oncology, Inc. in?

    Cardiff Oncology, Inc. is in the Healthcare sector

    What industry is Cardiff Oncology, Inc. in?

    Cardiff Oncology, Inc. is in the Biotechnology industry

    What country is Cardiff Oncology, Inc. based in?

    Cardiff Oncology, Inc. is headquartered in United States

    When did Cardiff Oncology, Inc. go public?

    Cardiff Oncology, Inc.'s initial public offering (IPO) was on July 27, 2004

    Is Cardiff Oncology, Inc. in the S&P 500?

    No, Cardiff Oncology, Inc. is not included in the S&P 500 index

    Is Cardiff Oncology, Inc. in the NASDAQ 100?

    No, Cardiff Oncology, Inc. is not included in the NASDAQ 100 index

    Is Cardiff Oncology, Inc. in the Dow Jones?

    No, Cardiff Oncology, Inc. is not included in the Dow Jones index

    When was Cardiff Oncology, Inc.'s last earnings report?

    Cardiff Oncology, Inc.'s most recent earnings report was on May 8, 2025

    When does Cardiff Oncology, Inc. report earnings?

    The next expected earnings date for Cardiff Oncology, Inc. is November 6, 2025
    On this page